MedTrace Logo

The Preemptive Analgetic Potency of Low Dose S-Ketamine

NCT01022840 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-10-02

No results posted yet for this study

Summary

The primary hypothesis is improved postoperative analgetic quality using S-Ketamine, particularly in patients suffering from chronic pain.

Conditions

Interventions

DRUG

S-Ketamine

drug

OTHER

Placebo Comparison

saline control

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Mischa Wejbora, MD · Med. U Graz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-03-31
Completion
2012-09-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01022840 on ClinicalTrials.gov